Portfolio Holdings Detail for ISIN IE00BHZPJ569
Stock Name / Fund iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker EGMW(GBP) LSE
ETF Ticker EDMWx(GBP) CXE
ETF Ticker ENWD.MI(EUR) CXE
ETF Ticker ENWD(EUR) ETF Plus
ETF Ticker EGMW.L(GBP) LSE

Holdings detail for REGN

Stock Name	Regeneron Pharmaceuticals Inc
Ticker	REGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75886F1075
LEI	549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria: (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL: Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors: Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN: In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC: Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.: Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.: D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP REGN holdings

Date	Number of REGN Shares Held	Base Market Value of REGN Shares	Local Market Value of REGN Shares	Change in REGN Shares Held	Change in REGN Base Value	Current Price per REGN Share Held	Previous Price per REGN Share Held
2025-11-10 (Monday)	2,417	USD 1,582,507	USD 1,582,507	12	USD 26,785	USD 654.74	USD 646.87
2025-11-06 (Thursday)	2,405	USD 1,555,722	USD 1,555,722	0	USD 6,445	USD 646.87	USD 644.19
2025-11-05 (Wednesday)	2,405	USD 1,549,277	USD 1,549,277	28	USD 22,649	USD 644.19	USD 642.25
2025-11-03 (Monday)	2,377	USD 1,526,628	USD 1,526,628	0	USD -22,701	USD 642.25	USD 651.8
2025-10-31 (Friday)	2,377	USD 1,549,329	USD 1,549,329	0	USD -2,638	USD 651.8	USD 652.91
2025-10-29 (Wednesday)	2,377	USD 1,551,967	USD 1,551,967	0	USD -3,732	USD 652.91	USD 654.48
2025-10-28 (Tuesday)	2,377	USD 1,555,699	USD 1,555,699	0	USD 164,417	USD 654.48	USD 585.31
2025-10-27 (Monday)	2,377	USD 1,391,282	USD 1,391,282	-20	USD 11,353	USD 585.31	USD 575.69

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00BHZPJ569

Show aggregate share trades of REGN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 12 665.990 653.190 654.470 USD 7,854 641.00
2025-11-05 BUY 28 646.895 628.000 629.890 USD 17,637 640.95
2025-10-27 SELL -20 585.310 586.150 586.066 USD -11,721 641.05 Profit of 1,100 on sale
2025-10-21 SELL -12 579.340 582.410 582.103 USD -6,985 642.04 Profit of 719 on sale
2025-10-15 BUY 72 576.420 584.870 584.025 USD 42,050 643.16
2025-10-03 SELL -24 600.000 618.010 616.209 USD -14,789 643.80 Profit of 662 on sale
2025-10-02 BUY 4 600.000 605.410 604.869 USD 2,419 644.04
2025-09-26 BUY 12 563.900 564.610 564.539 USD 6,774 645.71
2025-09-24 SELL -24 576.980 577.980 577.880 USD -13,869 646.63 Profit of 1,650 on sale
2025-07-24 BUY 40 564.640 577.730 576.421 USD 23,057 650.82
2025-07-23 BUY 16 572.390 576.700 576.269 USD 9,220 651.30
2025-07-16 BUY 4 547.930 558.350 557.308 USD 2,229 653.86
2025-07-10 SELL -20 559.760 566.370 565.709 USD -11,314 656.26 Profit of 1,811 on sale
2025-07-02 BUY 8 547.740 551.500 551.124 USD 4,409 660.69
2025-06-02 SELL -16 490.810 502.560 501.385 USD -8,022 685.37 Profit of 2,944 on sale
2025-05-30 BUY 24 490.280 519.780 516.830 USD 12,404 686.92
2025-05-29 SELL -12 605.390 605.730 605.696 USD -7,268 687.57 Profit of 983 on sale
2025-05-28 SELL -4 591.850 606.000 604.585 USD -2,418 688.34 Profit of 335 on sale
2025-05-22 SELL -60 596.850 605.500 604.635 USD -36,278 691.48 Profit of 5,211 on sale
2025-05-16 BUY 8 594.320 595.190 595.103 USD 4,761 694.55
2025-05-14 BUY 12 571.360 580.560 579.640 USD 6,956 696.59
2025-05-13 BUY 68 574.160 575.050 574.961 USD 39,097 697.67
2025-05-12 SELL -4 575.630 577.990 577.754 USD -2,311 698.76 Profit of 484 on sale
2025-04-23 SELL -8 587.850 603.770 602.178 USD -4,817 714.13 Profit of 896 on sale
2025-04-22 SELL -40 585.490 587.100 586.939 USD -23,478 715.44 Profit of 5,140 on sale
2025-04-11 BUY 8 554.180 555.530 555.395 USD 4,443 727.39
2025-04-09 BUY 8 576.720 580.730 580.329 USD 4,643 731.12
2025-04-08 SELL -20 556.810 586.030 583.108 USD -11,662 733.10 Profit of 3,000 on sale
2025-04-07 SELL -28 572.780 591.540 589.664 USD -16,511 734.94 Profit of 4,068 on sale
2025-04-04 BUY 4 573.450 612.990 609.036 USD 2,436 736.82
2025-03-27 BUY 16 635.830 643.430 642.670 USD 10,283 743.42
2025-03-11 BUY 100 718.160 747.700 744.746 USD 74,475 756.37
2025-03-07 BUY 8 707.510 729.750 727.526 USD 5,820 757.27
2025-03-06 BUY 8 698.440 701.000 700.744 USD 5,606 758.16
2025-03-03 SELL -16 684.870 704.640 702.663 USD -11,243 761.76 Profit of 946 on sale
2025-02-26 BUY 164 706.940 721.410 719.963 USD 118,074 764.71
2025-02-18 SELL -108 680.000 689.950 688.955 USD -74,407 771.92 Profit of 8,961 on sale
2025-02-13 BUY 16 674.270 677.690 677.348 USD 10,838 777.69
2024-12-09 BUY 8 788.000 800.990 799.691 USD 6,398 817.02
2024-12-04 SELL -20 754.260 756.130 755.943 USD -15,119 821.89 Profit of 1,319 on sale
2024-12-03 SELL -88 749.570 770.000 767.957 USD -67,580 824.30 Profit of 4,958 on sale
2024-11-25 SELL -524 749.510 757.860 757.025 USD -396,681 850.07 Profit of 48,758 on sale
2024-11-25 SELL -524 749.510 757.860 757.025 USD -396,681 850.07 Profit of 48,758 on sale
2024-11-19 SELL -5 744.600 758.600 757.200 USD -3,786 873.95 Profit of 584 on sale
2024-11-18 SELL -5 762.000 762.700 762.630 USD -3,813 880.54 Profit of 590 on sale
2024-11-12 BUY 15 821.000 831.000 830.000 USD 12,450 884.26
2024-11-01 SELL -40 843.600 862.000 860.160 USD -34,406 927.90 Profit of 2,710 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	12	665.990	653.190	654.470	USD 7,854	641.00
2025-11-05	BUY	28	646.895	628.000	629.890	USD 17,637	640.95
2025-10-27	SELL	-20	585.310	586.150	586.066	USD -11,721	641.05 Profit of 1,100 on sale
2025-10-21	SELL	-12	579.340	582.410	582.103	USD -6,985	642.04 Profit of 719 on sale
2025-10-15	BUY	72	576.420	584.870	584.025	USD 42,050	643.16
2025-10-03	SELL	-24	600.000	618.010	616.209	USD -14,789	643.80 Profit of 662 on sale
2025-10-02	BUY	4	600.000	605.410	604.869	USD 2,419	644.04
2025-09-26	BUY	12	563.900	564.610	564.539	USD 6,774	645.71
2025-09-24	SELL	-24	576.980	577.980	577.880	USD -13,869	646.63 Profit of 1,650 on sale
2025-07-24	BUY	40	564.640	577.730	576.421	USD 23,057	650.82
2025-07-23	BUY	16	572.390	576.700	576.269	USD 9,220	651.30
2025-07-16	BUY	4	547.930	558.350	557.308	USD 2,229	653.86
2025-07-10	SELL	-20	559.760	566.370	565.709	USD -11,314	656.26 Profit of 1,811 on sale
2025-07-02	BUY	8	547.740	551.500	551.124	USD 4,409	660.69
2025-06-02	SELL	-16	490.810	502.560	501.385	USD -8,022	685.37 Profit of 2,944 on sale
2025-05-30	BUY	24	490.280	519.780	516.830	USD 12,404	686.92
2025-05-29	SELL	-12	605.390	605.730	605.696	USD -7,268	687.57 Profit of 983 on sale
2025-05-28	SELL	-4	591.850	606.000	604.585	USD -2,418	688.34 Profit of 335 on sale
2025-05-22	SELL	-60	596.850	605.500	604.635	USD -36,278	691.48 Profit of 5,211 on sale
2025-05-16	BUY	8	594.320	595.190	595.103	USD 4,761	694.55
2025-05-14	BUY	12	571.360	580.560	579.640	USD 6,956	696.59
2025-05-13	BUY	68	574.160	575.050	574.961	USD 39,097	697.67
2025-05-12	SELL	-4	575.630	577.990	577.754	USD -2,311	698.76 Profit of 484 on sale
2025-04-23	SELL	-8	587.850	603.770	602.178	USD -4,817	714.13 Profit of 896 on sale
2025-04-22	SELL	-40	585.490	587.100	586.939	USD -23,478	715.44 Profit of 5,140 on sale
2025-04-11	BUY	8	554.180	555.530	555.395	USD 4,443	727.39
2025-04-09	BUY	8	576.720	580.730	580.329	USD 4,643	731.12
2025-04-08	SELL	-20	556.810	586.030	583.108	USD -11,662	733.10 Profit of 3,000 on sale
2025-04-07	SELL	-28	572.780	591.540	589.664	USD -16,511	734.94 Profit of 4,068 on sale
2025-04-04	BUY	4	573.450	612.990	609.036	USD 2,436	736.82
2025-03-27	BUY	16	635.830	643.430	642.670	USD 10,283	743.42
2025-03-11	BUY	100	718.160	747.700	744.746	USD 74,475	756.37
2025-03-07	BUY	8	707.510	729.750	727.526	USD 5,820	757.27
2025-03-06	BUY	8	698.440	701.000	700.744	USD 5,606	758.16
2025-03-03	SELL	-16	684.870	704.640	702.663	USD -11,243	761.76 Profit of 946 on sale
2025-02-26	BUY	164	706.940	721.410	719.963	USD 118,074	764.71
2025-02-18	SELL	-108	680.000	689.950	688.955	USD -74,407	771.92 Profit of 8,961 on sale
2025-02-13	BUY	16	674.270	677.690	677.348	USD 10,838	777.69
2024-12-09	BUY	8	788.000	800.990	799.691	USD 6,398	817.02
2024-12-04	SELL	-20	754.260	756.130	755.943	USD -15,119	821.89 Profit of 1,319 on sale
2024-12-03	SELL	-88	749.570	770.000	767.957	USD -67,580	824.30 Profit of 4,958 on sale
2024-11-25	SELL	-524	749.510	757.860	757.025	USD -396,681	850.07 Profit of 48,758 on sale
2024-11-25	SELL	-524	749.510	757.860	757.025	USD -396,681	850.07 Profit of 48,758 on sale
2024-11-19	SELL	-5	744.600	758.600	757.200	USD -3,786	873.95 Profit of 584 on sale
2024-11-18	SELL	-5	762.000	762.700	762.630	USD -3,813	880.54 Profit of 590 on sale
2024-11-12	BUY	15	821.000	831.000	830.000	USD 12,450	884.26
2024-11-01	SELL	-40	843.600	862.000	860.160	USD -34,406	927.90 Profit of 2,710 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	208,659	1,635	312,812	66.7%
2025-09-18	236,485	3,679	387,519	61.0%
2025-09-17	229,191	716	370,895	61.8%
2025-09-16	173,632	584	271,020	64.1%
2025-09-15	204,491	251	334,496	61.1%
2025-09-12	117,504	33	222,760	52.7%
2025-09-11	125,478	3,137	286,516	43.8%
2025-09-10	195,068	481	339,885	57.4%
2025-09-09	129,168	994	274,520	47.1%
2025-09-08	250,895	396	527,062	47.6%
2025-09-05	170,149	290	289,566	58.8%
2025-09-04	188,227	2,103	360,619	52.2%
2025-09-03	185,679	344	438,111	42.4%
2025-09-02	191,954	138	476,288	40.3%
2025-08-29	133,226	685	236,726	56.3%
2025-08-28	116,560	2,177	256,675	45.4%
2025-08-27	113,719	465	243,836	46.6%
2025-08-26	210,376	450	400,199	52.6%
2025-08-25	149,130	68	363,377	41.0%
2025-08-22	211,822	3,244	701,770	30.2%
2025-08-21	257,492	3,416	446,439	57.7%
2025-08-20	327,738	572	559,133	58.6%
2025-08-19	118,472	2,191	324,311	36.5%
2025-08-18	146,282	388	277,909	52.6%
2025-08-15	209,923	3,375	441,752	47.5%
2025-08-14	157,569	3,623	429,327	36.7%
2025-08-13	111,342	233	362,786	30.7%
2025-08-12	117,647	171	310,775	37.9%
2025-08-11	129,513	2,676	284,757	45.5%
2025-08-08	128,559	1,038	431,841	29.8%
2025-08-07	166,648	1,560	352,877	47.2%
2025-08-06	176,311	624	397,089	44.4%
2025-08-05	154,257	115	353,744	43.6%
2025-08-04	200,758	1,913	409,897	49.0%
2025-08-01	349,775	3,745	728,720	48.0%
2025-07-31	222,350	476	549,344	40.5%
2025-07-30	106,839	1,689	231,761	46.1%
2025-07-29	149,359	276	292,667	51.0%
2025-07-28	103,687	1,380	245,287	42.3%
2025-07-25	103,783	556	259,069	40.1%
2025-07-24	156,974	2,397	291,677	53.8%
2025-07-23	168,734	1,708	355,372	47.5%
2025-07-22	116,324	617	304,880	38.2%
2025-07-21	98,482	900	250,107	39.4%
2025-07-18	183,174	1,051	391,909	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	EGMW(GBP) LSE
ETF Ticker	EDMWx(GBP) CXE
ETF Ticker	ENWD.MI(EUR) CXE
ETF Ticker	ENWD(EUR) ETF Plus
ETF Ticker	EGMW.L(GBP) LSE